<DOC>
	<DOCNO>NCT01900938</DOCNO>
	<brief_summary>The aim study compare sedation efficiency , safety satisfaction endoscopist , assistant , patient continuous infusion intermittent bolus injection propofol deep sedation ERCP .</brief_summary>
	<brief_title>Comparison Between Continuous Infusion Intermittent Bolus Injection Propofol Deep Sedation During ERCP</brief_title>
	<detailed_description>The patient undergone ERCP randomly assign either continuous infusion propofol ( continuous group ) midazolam plus intermittent bolus injection propofol ( intermittent group ) deep sedation . In continuous group , propofol continuously administer via infusion pump dos determine sedation assistant monitor patient . In intermittent group , load dose 2 mg midazolam 0.4 mg/kg propofol initially inject repeated bolus injection 20 mg propofol follow accord patient ' sedation level . Sedation related parameter ( total dose propofol , induction/recovery time , patient ' cooperation ) adverse event procedure evaluate . Satisfaction score endoscopist , assistant , patient difficulty score maintain sedation assistant also grade procedure .</detailed_description>
	<mesh_term>Pancreatic Diseases</mesh_term>
	<mesh_term>Biliary Tract Diseases</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Patients undergone ERCP biliary pancreatic disease Comorbid condition ASA class 45 Age 18 year 90 year Pregnancy Past medication history benzodiazepine narcotic Known allergy midazolam propofol hypotension ( systolic blood pressure &lt; 90 mmHg ) , hypoxemia ( SaO2 &lt; 90 % ) , bradycardia ( 50/min ) baseline measurement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Cholangiopancreatography</keyword>
	<keyword>Endoscopic Retrograde</keyword>
</DOC>